Milestone Scientific, Inc. Common Stock

MLSS

Milestone Scientific, Inc. (MLSS) develops and manufactures innovative computer-controlled anesthesia delivery systems for dental and medical procedures. The company focuses on enhancing patient comfort and clinician precision through its advanced injection technology.

$0.44 +0.02 (4.05%)
🚫 Milestone Scientific, Inc. Common Stock does not pay dividends

Company News

Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025
GlobeNewswire Inc. • Eric Hines (Ceo) • November 13, 2025

Milestone Scientific reported stable Q3 2025 revenues of $2.4 million, reduced operating expenses by over $500,000, and continued advancing its dental and medical segment strategies with focus on cost management and growth initiatives.

Milestone Scientific Appoints Highly Accomplished MedTech Executive Shanth Thiyagalingam to Board of Directors
GlobeNewswire Inc. • N/A • May 19, 2025

Milestone Scientific Inc. has appointed Shanth Thiyagalingam, a seasoned MedTech executive, to its Board of Directors. Thiyagalingam brings extensive experience in commercial leadership, reimbursement strategy, and global market insights, which will support Milestone's growth across medical and dental segments.

Milestone Scientific Announces Commercial Rollout of CompuFlo® Epidural System at Advanced Spine and Pain Management Following Successful Pilot with Dr. Varinder Dhillon
GlobeNewswire Inc. • N/A • January 23, 2025

Milestone Scientific announced the commercial rollout of its CompuFlo® Epidural System at Advanced Spine and Pain Management, following a successful pilot program. The company also reported increasing adoption of the system after a Medicare price assignment, highlighting its clinical and economic benefits.

Milestone Scientific to Present at The Benchmark Company’s Upcoming Discovery One-on-One Investor Conference on December 11th, 2024
GlobeNewswire Inc. • Milestone Scientific Inc. • December 4, 2024

Milestone Scientific Inc., a medical technology company, announced that its CEO and Chairman will be presenting at The Benchmark Company's investor conference on December 11th, 2024. The conference offers emerging growth companies access to institutional and individual investors in a one-on-one format.

EXCLUSIVE: Milestone Scientific Announces Medicare Price Assignment For CompuFlo Epidural System For Back Pain Covering Additional US States - Benzinga
Benzinga • Vandana Singh • July 23, 2024

Milestone Scientific's CompuFlo Epidural System has received Medicare price assignment in additional US states, representing a significant addressable market for the company's technology.

Related Companies